Sven Jonas

10.3k total citations · 2 hit papers
230 papers, 7.4k citations indexed

About

Sven Jonas is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Sven Jonas has authored 230 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Surgery, 78 papers in Hepatology and 55 papers in Transplantation. Recurrent topics in Sven Jonas's work include Organ Transplantation Techniques and Outcomes (88 papers), Renal Transplantation Outcomes and Treatments (55 papers) and Liver Disease and Transplantation (48 papers). Sven Jonas is often cited by papers focused on Organ Transplantation Techniques and Outcomes (88 papers), Renal Transplantation Outcomes and Treatments (55 papers) and Liver Disease and Transplantation (48 papers). Sven Jonas collaborates with scholars based in Germany, United States and France. Sven Jonas's co-authors include P. Neuhaus, Wolf O. Bechstein, P. Neuhaus, Armin Thelen, Utz Settmacher, Cornelia Radke, Christoph Benckert, Ulf P. Neumann, Thomas Berg and Jan M. Langrehr and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sven Jonas

224 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis

2001 720 citations Sven Jonas, Wolf O. Bechstein et al. Hepatology profile →
Extended Resections for Hilar Cholangiocarcinoma

1999 488 citations P. Neuhaus, Sven Jonas et al. Annals of Surgery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sven Jonas	4.1k	2.8k	2.0k	1.6k	1.5k	230	7.4k
Jürgen Klempnauer	4.8k 1.2×	3.4k 1.2×	1.6k 0.8×	1.6k 1.0×	2.2k 1.4×	296	8.7k
Karim Boudjéma	4.8k 1.2×	5.0k 1.8×	2.9k 1.4×	1.9k 1.2×	1.7k 1.1×	292	8.9k
Georgios C. Sotiropoulos	2.8k 0.7×	2.2k 0.8×	1.5k 0.7×	1.2k 0.8×	1.4k 1.0×	221	5.4k
Matteo Ravaioli	4.1k 1.0×	5.2k 1.8×	1.7k 0.9×	1.1k 0.7×	2.8k 1.8×	279	8.2k
Henrik Petrowsky	4.5k 1.1×	4.3k 1.5×	2.0k 1.0×	1.0k 0.6×	2.3k 1.5×	139	7.5k
Giorgio Ercolani	5.2k 1.3×	5.9k 2.1×	2.5k 1.2×	2.0k 1.2×	3.4k 2.2×	349	9.7k
Derek Manas	2.4k 0.6×	1.7k 0.6×	1.2k 0.6×	1.1k 0.7×	1.2k 0.8×	199	5.1k
Charles B. Rosen	6.7k 1.6×	4.9k 1.7×	2.1k 1.0×	3.2k 2.0×	2.8k 1.8×	151	9.4k
Mohamed Rela	5.6k 1.4×	4.7k 1.7×	1.0k 0.5×	999 0.6×	2.1k 1.4×	439	9.3k
Gi‐Won Song	3.9k 1.0×	3.5k 1.3×	1.2k 0.6×	945 0.6×	1.5k 1.0×	374	5.7k

Countries citing papers authored by Sven Jonas

Since Specialization

Citations

This map shows the geographic impact of Sven Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Jonas more than expected).

Fields of papers citing papers by Sven Jonas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Jonas. The network helps show where Sven Jonas may publish in the future.

Co-authorship network of co-authors of Sven Jonas

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Jonas. A scholar is included among the top collaborators of Sven Jonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Jonas. Sven Jonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atanasov, Georgi, Katrin Schierle, Hans‐Michael Hau, et al.. (2016). Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma. Annals of Surgical Oncology. 24(2). 518–525. 22 indexed citations

Tautenhahn, Hans‐Michael, Dirk Uhlmann, Moritz Schmelzle, et al.. (2014). Single-center experience using organs after rescue allocation for pancreas transplant in the eurotransplant region.. PubMed. 12(4). 351–6. 4 indexed citations

Singer, Susanne, Susanne Briest, Alison Brown, et al.. (2013). Co‐morbid mental health conditions in cancer patients at working age – prevalence, risk profiles, and care uptake. Psycho-Oncology. 22(10). 2291–2297. 60 indexed citations

Simone, Paolo De, Frederik Nevens, Luciano De Carlis, et al.. (2012). Renal function with everolimus and reduced tacrolimus in de novo liver transplant recipients: 12 month results of the H2304 trial. O-17. Liver Transplantation. 18. 5 indexed citations

Fung, John J., Frederik Nevens, Luciano De Carlis, et al.. (2012). Everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients - 12 month efficacy and safety results from the H2304 study. American Journal of Transplantation. 12. 28–28. 1 indexed citations

Simone, Paolo De, Frederik Nevens, Luciano De Carlis, et al.. (2012). Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study. American Journal of Transplantation. 12(3). 238–238. 1 indexed citations

Saliba, Faouzi, Paolo De Simone, Frederik Nevens, et al.. (2011). Efficacy and safety of everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients: 12 month results of a phase iii, randomized, controlled study. Hepatology. 54. 1 indexed citations

Kassahun, Woubet Tefera & Sven Jonas. (2010). Focus on parathyroid carcinoma. International Journal of Surgery. 9(1). 13–19. 55 indexed citations

Pfander, David, Wilko Weichert, Nadine Rohwer, et al.. (2009). Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochemistry and Cell Biology. 132(1). 21–31. 34 indexed citations

10.

Ulrich, Frank, Johann Pratschke, Andreas Pascher, et al.. (2008). Long-Term Outcome of Liver Resection and Transplantation for Caroli Disease and Syndrome. Annals of Surgery. 247(2). 357–364. 39 indexed citations

11.

Jonas, Sven, Jens Mittler, Andreas Pascher, et al.. (2007). Living Donor Liver Transplantation of the Right Lobe for Hepatocellular Carcinoma in Cirrhosis in a European Center. Liver Transplantation. 13(6). 896–903. 34 indexed citations

12.

Oertel, Stephan, Ralf Ulrich Trappe, Kristin Zeidler, et al.. (2006). Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Annals of Hematology. 85(7). 478–484. 30 indexed citations

13.

Heidenhain, Christoph, Anja Reutzel‐Selke, Ulrike Bachmann, et al.. (2003). The impact of immune-activating processes following transplantation on chronic allograft nephropathy. Kidney International. 64(3). 1125–1133. 3 indexed citations

14.

Lohmann, R, Jan M. Langrehr, J Klupp, et al.. (2000). Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimens. Transplantation Proceedings. 32(3). 537–538. 3 indexed citations

15.

Reutzel‐Selke, Anja, Melina Nieminen-Kelhä, Sven Jonas, et al.. (2000). Contribution of Prolonged Ischemia and Donor Age to Chronic Renal Allograft Dysfunction. Journal of the American Society of Nephrology. 11(7). 1317–1324. 100 indexed citations

16.

Heinze, Thomas M., et al.. (1999). Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time.. PubMed. 19(4A). 2501–3. 36 indexed citations

17.

Tullius, Stefan G., Melina Nieminen-Kelhä, Wolf O. Bechstein, et al.. (1998). Prompt treatment of initial acute rejection episodes may improve long-term graft outcome. Transplant International. 11(0). S3–S4. 5 indexed citations

18.

Langrehr, Jan M., Andreas Kahl, Markus Meyer, et al.. (1997). Prophylactic use of low‐dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo‐controlled study. Clinical Transplantation. 11(6). 593–598. 14 indexed citations

19.

Jonas, Sven, Wolf O. Bechstein, Thomas M. Heinze, et al.. (1997). Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resection. Surgery. 121(4). 456–461. 21 indexed citations

20.

Platz, Klaus‐Peter, Andrea Mueller, Sven Jonas, et al.. (1995). Toxicity versus rejection ‐ Or why conversions between cyclosporine A and FK506 were performed after liver transplantation. Clinical Transplantation. 9(3pt1). 146–154. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact